Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor

Alevizopoulos, Konstantinos; Dimas, Konstantinos; Papadopoulou, Natalia; Schmidt, Eva-Maria; Tsapara, Anna; Alkahtani, Saad; Honisch, Sabina; Prousis, Kyriakos C.; Alarifi, Saud; Calogeropoulou, Theodora; Lang, Florian; Stournaras, Christos

dc.contributor.author	Schmidt, Eva-Maria
dc.contributor.author	Honisch, Sabina
dc.contributor.author	Lang, Florian
dc.contributor.author	Stournaras, Christos
dc.date.accessioned	2017-02-10T12:12:26Z
dc.date.available	2017-02-10T12:12:26Z
dc.date.issued	2016
dc.identifier.issn	1949-2553
dc.identifier.uri	http://hdl.handle.net/10900/74404
dc.language.iso	en	de_DE
dc.publisher	Impact Journals Llc	de_DE
dc.relation.uri	http://dx.doi.org/10.18632/oncotarget.8329	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160915142648_00985
utue.publikation.seiten	24415-24428	de_DE
utue.personen.roh	Alevizopoulos, Konstantinos
utue.personen.roh	Dimas, Konstantinos
utue.personen.roh	Papadopoulou, Natalia
utue.personen.roh	Schmidt, Eva-Maria
utue.personen.roh	Tsapara, Anna
utue.personen.roh	Alkahtani, Saad
utue.personen.roh	Honisch, Sabina
utue.personen.roh	Prousis, Kyriakos C.
utue.personen.roh	Alarifi, Saud
utue.personen.roh	Calogeropoulou, Theodora
utue.personen.roh	Lang, Florian
utue.personen.roh	Stournaras, Christos
dcterms.isPartOf.ZSTitelID	Oncotarget	de_DE
dcterms.isPartOf.ZS-Issue	17	de_DE
dcterms.isPartOf.ZS-Volume	7	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE